Literature DB >> 12624597

Infection control during gastrointestinal endoscopy.

Douglas B Nelson1.   

Abstract

Infection-control issues during gastrointestinal endoscopy, which are becoming increasingly important, can generally be divided into three major areas: (1) infectious complications resulting from a patient's own microbial flora (autologous), (2) infections transmitted from patient to patient by way of the endoscope (exogenous), and (3) infections transmitted between the patient and the health-care provider. The mean frequency of postprocedure bacteremia ranges from 0.5% for flexible sigmoidoscopy to 2.2% for colonoscopy, 4.2% for esophagogastroduodenoscopy, 8.9% for variceal ligation, 11% for endoscopic retrograde cholangiopancreatography, 15.4% for variceal sclerotherapy, and 22.8% for esophageal dilation. Although postprocedure bacteremia is not uncommon, it seldom results in infectious complications. Exogenous infections transmitted during endoscopy, which are extremely rare, generally result from failure to follow accepted guidelines for the cleaning and disinfection of gastrointestinal endoscopes, underscoring the importance of meticulous attention to endoscope reprocessing. Finally, although the risk of patient-staff transmission of infection is also rare, standard infection-control recommendations are important in protecting both patients and health-care providers.

Entities:  

Mesh:

Year:  2003        PMID: 12624597     DOI: 10.1067/mlc.2003.24

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  10 in total

1.  Epidemiology and Prevention of Infections Related to Endoscopy.

Authors:  Arjun Srinivasan
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

2.  Current GI endoscope disinfection and QA practices.

Authors:  Frank M Moses; Jennifer S Lee
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 3.  Is peracetic acid suitable for the cleaning step of reprocessing flexible endoscopes?

Authors:  Günter Kampf; Patricia M Fliss; Heike Martiny
Journal:  World J Gastrointest Endosc       Date:  2014-09-16

4.  Primary Staphylococcus aureus urinary tract infection: the role of undetected hematogenous seeding of the urinary tract.

Authors:  I G Baraboutis; E P Tsagalou; J L Lepinski; I Papakonstantinou; V Papastamopoulos; A T Skoutelis; S Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-30       Impact factor: 3.267

5.  Intestinal obstruction associated with chronic peritonitis caused by Sphingomonas paucimobilis.

Authors:  Alberto Di Leo; Rosanna Busetti; Teresa Pusiol; Francesco Piscioli; Ilaria Franceschetti; Francesco Ricci
Journal:  Clin J Gastroenterol       Date:  2009-02-27

Review 6.  Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy.

Authors:  Julia Kovaleva; Frans T M Peters; Henny C van der Mei; John E Degener
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

7.  Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems.

Authors:  Jean-Yves Maillard
Journal:  Ther Clin Risk Manag       Date:  2005-12       Impact factor: 2.423

8.  Bacteremia after Endoscopic Submucosal Excavation for Treating the Gastric Muscular Layer Tumors.

Authors:  Guohua Li; Sheng Zeng; Youxiang Chen; Xiaojiang Zhou; Nonghua Lv
Journal:  Gastroenterol Res Pract       Date:  2015-04-28       Impact factor: 2.260

9.  A case report of iatrogenic gas gangrene post colonoscopy successfully treated with conservative management- is surgery always necessary?

Authors:  Lachlan J Fairley; Samuel L Smith; Stephen K Fairley
Journal:  BMC Gastroenterol       Date:  2020-05-27       Impact factor: 3.067

10.  The State of Microbiological Cleanliness of Surfaces and Equipment of an Endoscopic Examination Laboratory-Data from a Reference Tertiary Clinical Endoscopy Center in Southern Poland.

Authors:  Jolanta Gruszecka; Rafał Filip; Dorota Gutkowska
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.